Sign In
Buy ABT
$90.53
+2.76 (+3.14%)
At Close: Jun 23, 2026
3 Dividend Stocks You Can Buy and Hold for Decades
05:52am, Friday, 13'th May 2022
You can really think long term with these great dividend stocks.
As a baby formula shortage worsens, Abbott says it can get some product back on store shelves in July
01:54pm, Thursday, 12'th May 2022 MarketWatch
The company said it can restart production of its baby formulas at a plant in Michigan within two weeks if U.S. regulators allow it to do so.
Baby Formula Shortage: How Safety Concerns At An Abbott Facility Fueled A Crisis
01:15pm, Thursday, 12'th May 2022
A whistleblower report released last month showed a former Abbott employee brought concerns about the facility months before the FDA issued a recall.
Should You Invest in the iShares U.S. Medical Devices ETF (IHI)?
10:20am, Thursday, 12'th May 2022 Zacks Investment Research
Sector ETF report for IHI
Abbott says it will be at least two months before baby formula from shuttered plant hits shelves
05:55pm, Wednesday, 11'th May 2022
Abbott Nutrition, a major U.S. formula manufacturer, says it will be at least two months before baby formula made at its closed Sturgis, Michigan, plant will hit stores shelves after it reopens "subje
Abbott could restart infant formula production at Michigan plant
02:35pm, Wednesday, 11'th May 2022
Abbott Laboratories said on Wednesday it could restart production of infant formula at its troubled Michigan facility within two weeks.
As a shortage worsens, Abbott says it can get baby formula back on store shelves in June
01:28pm, Wednesday, 11'th May 2022
Abbott Laboratories ABT, -0.42% said it can restart production of its baby formulas at a plant in Michigan within two weeks if U.S. regulators allow it to do so.
Q1 Earnings Scorecard and Analyst Reports for AbbVie, QUALCOMM & Linde
06:58pm, Tuesday, 10'th May 2022 Zacks Investment Research
Today's Research Daily features a real-time update on the Q1 earnings season and new research reports on AbbVie (ABBV), QUALCOMM (QCOM), and Linde(LIN).
3 Medical Product Stocks Set to Beat on Earnings This Season
09:03am, Monday, 09'th May 2022
Medical product companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how CGC, HAE and ALC are poised ahead of their earnings releases.
AbbVie: Buy, Hold, Or Sell After Q1 Results?
01:00pm, Sunday, 08'th May 2022 Seeking Alpha
AbbVie stock was under heavy selling pressure following its Q1 ‘22 earnings. Check out whether ABBV stock is a buy, hold or sell after its Q1 earnings.
What's Next for Abbott Laboratories' Stock?
03:30pm, Saturday, 07'th May 2022 The Motley Fool
There are choppy waters ahead, but plenty of opportunity on the horizon.
2 Healthcare Stocks That Could Make You Richer
12:07pm, Saturday, 07'th May 2022 The Motley Fool
The long-term outlook seems great for both of these companies.
What's Next for Abbott Laboratories' Stock?
11:30am, Saturday, 07'th May 2022
There are choppy waters ahead, but plenty of opportunity on the horizon.
Tracking Ken Fisher's Fisher Asset Management Portfolio - Q1 2022 Update
05:44am, Saturday, 07'th May 2022 Seeking Alpha
Ken Fisher’s 13F portfolio value decreased from ~$179B to ~$165B in Q1 2022. Find more details here...
Abbott: Solid Conviction Pick
08:00am, Friday, 06'th May 2022
Abbott's Q1 2022 earnings support a strong buy thesis for this perennial outperformer, with all segments save nutrition performing at peak levels. Abbott's new product pipeline has provided epic pande
